Invention Grant
- Patent Title: Neprilysin inhibitors
- Patent Title (中): Neprilysin抑制剂
-
Application No.: US14180479Application Date: 2014-02-14
-
Publication No.: US09150500B2Publication Date: 2015-10-06
- Inventor: Adam D. Hughes , Erik Fenster , Melissa Fleury , Roland Gendron , Edmund J. Moran
- Applicant: Adam D. Hughes , Erik Fenster , Melissa Fleury , Roland Gendron , Edmund J. Moran
- Applicant Address: US CA South San Francisco
- Assignee: Theravance Biopharma R&D IP, LLC
- Current Assignee: Theravance Biopharma R&D IP, LLC
- Current Assignee Address: US CA South San Francisco
- Agent Jeffrey A. Hagenah
- Main IPC: A01N37/00
- IPC: A01N37/00 ; A61K31/21 ; C07C233/56 ; C07C271/22 ; C07D317/40 ; C07C231/02 ; C07C243/30 ; C07D319/06 ; C07D207/263
Abstract:
In one aspect, the invention relates to compounds having the formula: where R1-R6, a, b, and Z are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and processes and intermediates for preparing such compounds.
Public/Granted literature
- US20140343138A1 NEPRILYSIN INHIBITORS Public/Granted day:2014-11-20
Information query
